<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://equibles.com/research/intel-the-465-7b-market-cap-attached-to-a-57-0b-money-losing-business-has-one-quarter-to-prove-the-q2-2026-reset-2026-07-25</loc>
    <news:news>
      <news:publication>
        <news:name>Equibles Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-26T00:10:15Z</news:publication_date>
      <news:title>Intel: The $465.7B market cap attached to a $57.0B money-losing business has one quarter to prove the Q2 2026 reset</news:title>
    </news:news>
    <lastmod>2026-07-26</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/amd-at-171-1-earnings-is-the-cycle-s-most-multiple-expanding-bet-and-q2-2026-is-the-bar-2026-07-25</loc>
    <news:news>
      <news:publication>
        <news:name>Equibles Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-26T00:10:03Z</news:publication_date>
      <news:title>AMD at 171.1× earnings is the cycle&apos;s most multiple-expanding bet, and Q2 2026 is the bar</news:title>
    </news:news>
    <lastmod>2026-07-26</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/micron-s-fq4-26-guide-of-50-0b-and-86-gross-margin-a-single-quarter-larger-than-every-full-year-through-fy2024-with-sk-hynix-s-p-t7-build-as-the-contestable-mirror-2026-07-23</loc>
    <news:news>
      <news:publication>
        <news:name>Equibles Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-24T12:13:06Z</news:publication_date>
      <news:title>Micron&apos;s FQ4-26 guide of $50.0B and 86% gross margin: a single quarter larger than every full year through FY2024, with SK hynix&apos;s P&amp;T7 build as the contestable mirror</news:title>
    </news:news>
    <lastmod>2026-07-24</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/sofi-s-47-2-drawdown-prices-a-credit-cycle-casualty-the-q1-2026-print-disproves-2026-07-21</loc>
    <lastmod>2026-07-21</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/hims-hers-has-26-4-shorts-arguing-against-2-9b-of-guided-2026-revenue-the-q2-print-decides-whether-subscriber-growth-or-arpu-decay-wins-2026-07-19</loc>
    <lastmod>2026-07-19</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/rocket-lab-backlog-is-converting-but-the-39b-market-cap-is-paying-for-a-neutron-debut-the-company-has-yet-to-validate-2026-07-16</loc>
    <lastmod>2026-07-16</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/emergent-biosolutions-leveraged-biodefense-name-trades-like-a-narcan-story-while-international-mcm-mix-hits-37-2026-07-15</loc>
    <lastmod>2026-07-15</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/alexandria-real-estate-equities-stress-event-priced-in-dividend-reset-is-the-test-2026-07-14</loc>
    <lastmod>2026-07-14</lastmod>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/amd</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/arm</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/avgo</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/galdy</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/hln</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/intc</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/jhpcy</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/mu</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/nvda</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/skhy</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/tak</loc>
  </url>
  <url>
    <loc>https://equibles.com/research/stocks/tsm</loc>
  </url>
</urlset>
